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In Figure 2G of the above paper, the figure keywas incorrectly labeled. In the figure key, the filled square symbol (---) was labeled
as ‘‘ABL1–/–/ABL2 –/– + Imatinib.’’ The filled square should be labeled as ‘‘ABL1–/–/ABL2 –/–.’’ Please refer to the revised figure here.
In addition, correct version of the article is now online. We regret any inconvenience this has caused.Cell Host & Microbe 10, 635, December 15, 2011 ª2011 Elsevier Inc. 635
